(11:15 GMT) Genmab Price Target Raised to $40.00/Share From $38.00 by HC Wainwright & Co.
DO Dow Jones Newswires Genmab Is Maintained at Buy by HC Wainwright & Co. 7/2/2026, 07:15 PM GMT+8 Dow Jones Newswires GM GMAB (11:15 GMT) Genmab Price Target Raised to $40.00/Share From $38.00 by HC Wainwright & Co. Market News Dow Jones Newswires AbbVie, Genmab Blood-Cancer Drug Has Competitive Profile — Market Talk Dow Jones Newswires Genmab Shares Climb After Lymphoma Therapy Hits Goal in Trial Reuters Genmab Announces Positive Phase 3 Results For Epcoritamab Plus Lenalidomide Dow Jones Newswires AbbVie, Genmab's Lymphoma Treatment Meets Primary Endpoint in Phase 3 Trial
